Dr. Andrea Wang-Gillam , Chief Medical Officer of Jacobio, became one of the 10 elite doctors in the field of pancreatic cancer in the United States

On November 19, 2020, MediFind，an industry authority in the US，released 10 Elite Experts Leading the Fight Against Pancreatic Cancer in the US, and Dr. Andrea Wang-Gillam, Chief Medical Officer and Senior Vice President of Jacobio, was selected as one of the 10 elite doctors leading the fight against pancreatic cancer in the US.

As the company's CMO ,Dr. Andrea Wang-Gillam is responsible for leadership in strategical development of company’s pipeline and oversee its global clinical operation. Prior to joining Jacobio, Dr. Wang-Gillam, a pancreatic cancer expert, served as Clinical Director of Gastrointestinal Oncology Program, Director of Developmental Therapeutics Program (Phase I Program) in the Division of Oncology of Department of Medicine at Washington University School of Medicine in St. Louis. Dr. Wang-Gillam brings over 10 years of academic experience in clinical and translation research. Under her leadership, we will move forward steadily to provide breakthrough treatment options for patients around the world.